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A B S T R A C T
Reaction  of  p-toluenesulfonyl  chloride  with  amino  acids  gave  sulfonamides
p-T1a-k which upon amidation afforded p-T2a-k. Similarly, treatment  involving
α-toluenesulfonyl chloride and amino acids afforded the sulfonamides α-T1a-k.
These two classes of sulfonamides were synthetically modified at their COOH end
position to achieve N,N-diethylamido substituted p-toluenesulfonamides p-T2a-k
and α-toluenesulfonamides α-T2a-k, respectively. The chemical structures of the
compounds were validated with IR, Mass spectra, NMR as well as elemental
analytical data. Both classes of compounds were screened against Escherichia coli
and  Staphylococcus  aureus  and  their  activity  were compared. It was remarkable
to  note  that  the  α-toluene  sulfonamides  α-T2a-k  were  more  active  than their
p-toluenesulfonamide counterparts p-T2a-k. Compound 1-(benzylsulfonyl)-N,N-
diethylpyrrolidine-2-carboxamide α-T2a was the most potent antibacterial
compound on S. aureus with MIC value of 3.12 µg mLG1 while N,N-Diethyl-3-
phenyl-2-(phenylmethylsulfonamide) propanamide α-T2j emerged as the best
antibacterial motif against E. coli with MIC value of 12.5 µg mLG1. Hence, these
compounds especially the α-toluenesulfonamide core structural templates are good
candidates for further study for future drug discovery.
Key words: Sulfonamide, bacterial infection, drug resistance,  zone  of  inhibition,
Escherichia coli
INTRODUCTION
Sulfonamide drugs which have brought about an antibiotic
revolution in medicine are associated with a wide range of
biological activities. Sulfonamides inhibit the multiplication of
bacteria by acting as competitive inhibitors of p-aminobenzoic
acid (PABA) in the folic acid metabolism cycle. They have
been in clinical use since 1968 (Connor, 1998) and are known
to represent a class of medicinally important compounds which
are extensively used as antibacterial agents (Chohan et al.,
2010). Sulfonamides possess many types of biological
activities and many of them are widely used in therapeutic
medicine as analgesic (Zebardast et al., 2009), antimicrobial
(Ozbek et al., 2007), anticancer (Lopez et al., 2010),
antileishmanial (Bhattacharya et al., 2002), antitumor
(Alqasoumi et al., 2010), antidiabetic  (Berredjem et al.,
2015), antioxidant (Saeedi et  al.,  2014),  anticonvulsant
(Kiran et al., 2009), anti-HIV (Al-Soud et al., 2008)
antihypertensive (Bhagwat et al., 2014), anti-inflammatory
(Chowdhury et al., 2009), antimalarial (Miller et al., 2002),
antitubercular (Papadopoulou et al., 2014), antiviral,
antiplatelet aggregation (Wang et al.,  2003),  diuretic
(Supuran and Scozzafava, 2000) and anti-carbonic anhydrase
(Bertucci et al., 2009; Eroglu, 2008)  activities  among  others.
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Recently, a host of structurally novel sulfonamide derivatives
have been reported  to  show  substantial  antitumor  activity
in vitro and/or in vivo (Ismail et al., 2006). The chemistry of
sulfonamides has recently shown them to be highly efficient
synthons in the preparation of various valuable biologically
active compounds (Bahrami et al., 2009). A novel series of
potent thioether benzenesulfonamide inhibitors of carbonic
anhydrases II and IV was discovered using structure-based
drug design (Vernier et al., 2010). The sulfonamide dyes,
especially secondary sulfonamide dyes, exhibited superior dye
exhaustion and  color  fastnesses  to  washing,  sublimation
and rubbing  on  fine denier PP fabrics (Cui et al., 2009).
Many of  the  9-sulfonylamino  derivatives  exhibited
improved antibacterial activity against a number of
tetracycline and minocycline resistant gram-positive pathogens
(Sum et al., 2006).
Epidemiological studies have revealed that the emergent
of   new  diseases  is  on  the  increase  and    quite  alarming
(Jones et al., 2008). Multi-drug resistance is also one of the
major  immediate   threats   to   human   health   today
(Dyatkina et al., 2002). For instance, methicillin-resistant
staphylococci are resistant to many antibiotics such as
penicillin, carbapenems, cephems and beta-lactam, quinolone,
amino glycosides and tetracycline (Jain et al., 2004), whereas
sulfonamides and their combination therapies are  gaining
more attention by the day in  antimicrobial drug  research
(Genc et al., 2008). Thus, it is conceivable to develop a series
of functionalized sulfonamides with dialkylated amide side
chain modification on carboxyl functionality for possible
antibacterial efficacy. In view of the challenges above and
other wide pharmacological activities of sulfonamide
derivatives,  we  have  herein  embarked  on  the   synthesis
and    antibacterial    study   of   p-toluenesulfonamides   and
α-toluenesulfonamides in order to compare their biological
efficiency for future drug design.
MATERIALS AND METHODS
General: The melting points were determined on XT-4 Digital
Binocular Microscope melting point apparatus manufactured
by Beijing, Technical Instrument Co. Ltd. and were
uncorrected. The IR spectra were run on Varian Excalibur HE
3100 FT-IR Spectrometer while, the mass spectra were
obtained using Waters GCT Premier Spectrometer. The 1H-
NMR spectra were recorded in either CDCl3 or DMSO-d6 on
NMR Bruker DPX 400 spectrometer operating at 400 MHz.
Tetramethyl silane (TMS) was used as internal standard with
the deuterium signal of the solvent as the lock and chemical
shifts δ recorded in ppm. The elemental analyses (C, H, N) of
the compounds were performed using Flash EA 1112
Elemental Analyzer. The pH was monitored using Portable pH
Meter Model PHB4. All drying were conducted at reduced
pressure with DHG-9023A Vacuum Oven.  In addition,
column chromatographic purifications were carried out on the
products using CHCl3/CH3OH (9:1) solvent system and Merck
silica gel F (Mesh 200-300). Organic solutions were dried over
anhydrous Na2SO4 and concentrated with a RE-2000B Buchi
Rotary Evaporator. Commercially available materials were
used without further purification while other reagents were
used directly after ascertaining the purity condition.
Synthesis
General  procedure  for  p-toluenesulfonamide p-T1a-k: To
a  solution  of  amino  acid (12.5  mmol)  in  water (15 mL)
was  added  Na2CO3  (2.785   g,   26.25   mmol)  at  0°C  and
p-toluenesulfonyl chloride, p-TsCl (2.86 g, 15 mmol) in three
portions over a period of 1 h. The slurry was then warmed to
room temperature and allowed to stir for 48 h. Upon
completion of the reaction which was TLC monitored using
CHCl3/CH3OH solvent system (9:1), the reaction mixture was
acidified with 20%  concentrated  aqueous  HCl  solution  to
pH 2, after which crystallization occurred and the product was
obtained via suction filtration. The filtered crude product was
washed with pH  2.2 buffer and dried in a vacuum oven at
60°C for 12 h to afford p-toluenesulfonamides p-T1a-k. 
General   procedure   of   α-tolylsulfonamide   derivatives
p-T2a-k:  To  a  solution  of  L-amino  acid  (5 mmol) in H2O
(6 mL) was added Na2CO3 (1.113 g, 10.5 mmol) with
continuous stirring until all the solutes had dissolved. The
clear solution was cooled to -10°C and α-toluenesulfonyl
chloride, α-TsCl (1.144 g, 6 mmol) was added in three batches
over a period of 1 h. It was warmed up to 0°C and stirred there
for 1 h. Finally, the reacting mixture was then warmed up to
room temperature and allowed to stir there for 48 h. The
reaction was quenched by addition of DCM (10 mL) and
transferred into separatory funnel where the excess of α-TsCl
was removed by extraction. The aqueous layer was then
worked up to give a clear solution by addition of 2 N HCl until
the pH 2.2 was attained. The clear liquid was then lyophilized
at -52°C under reduced pressure for 12 h to obtain the crude
solid product which was purified by column chromatography
(CHCl3/CH3OH, 3:1) to afford α-toluene sulfonamides p-T2a-k
in excellent yields. 
General   procedure   of  N,N-diethyl-2-
(phenylmethylsulfonamido) propanamide, a-T2a-k: To a
solution   of     α-tolylsulfonamide     derivatives   a-T1a-k
(2.96 mmol) in H2O (10 mL) in a streaming flow of nitrogen
gas, was added oxalyl chloride (0.34 mL, 3.85 mmol, 1.30 eq.)
via dropping pipette followed by carefully controlled addition
of 1 drop of DMF. The resulting mixture was stirred at room
temperature for 2 h to get crude acid chloride which was kept
air-tighted prior to use. In a separate 250 mL three-necked
round bottom flask, equipped with  a  magnetic  stirring bar,
was  added   Na2CO3  (0.628  g,  5.92  mmol, 2 equiv.)  to H2O
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(10 mL) followed by diethyl amine DEA (0.4 mL, 3.85 mmol,
1.3 equiv.) in continuous stirring and cooled to -15°C. Then,
earlier kept acid chloride was added in such  a  way  to
maintain the internal temperature of the reaction mixture at
around-10°C. The reacting mixture was then stirred at -10°C
for 1 h; at 0°C for 1 h and finally at room temperature for 1 h.
The reaction was terminated, worked up  by  acidifying  with
2 N HCl and concentrated in rotary evaporator. The clear
solution obtained was freeze-dried to get crude solid product
which was purified by column chromatography
(CHCl3/CH3OH,  3:1)  to  afford  N,N-diethylalkanamide  of
α-tolylsulfonamide derivatives α-T2a-k.
Antibacterial activity assays: The antimicrobial properties of
the sulfonamides were investigated in form of the general
sensitivity testing and Minimum Inhibitory Concentration
(MIC) with respect to freshly cultured targeted organisms. The
two organisms of interest in this present study are one gram
positive (Staphylococcus aureus ATCC 6538) and one gram
negative (Escherichia coli  ATCC 25922) organisms which are
associated with the gastrointestinal tract damage in man and
animal.
Preparation  of  the   inoculum:  The   standard   strains   of
S. aureus and E. coli used were obtained from Test Center of
Antimicrobial Materials, TIPC, Beijing. No clinically isolated
organism was used based on in-availability of such as at the
time of this study. The strains were propagated on nutrient
agar plates and maintained on the plate at 4°C. The isolates
were sub-cultured in nutrient broth at 37°C for 8 h prior to
antibacterial testing.
Antibacterial sensitivity testing of the synthesized
compounds: Agar well diffusion technique as described by
Russell and Furr (1977), was used to determine the
antibacterial  activity  of  the   synthesized   compounds
(Russell and Furr, 1977). Sensitivity test agar plates were
seeded with 0.1 mL of an overnight culture of each bacterial
strain (equivalent to 107-108 CFU mLG1). The seeded plates
were allowed to set and a standard cork borer of 8 mm
diameter was used to cut uniform wells on the surface of the
agar. The wells were then filled with 0.3 mL of each
sulfonamide solution in appropriate solvent at  a concentration 
 of  1000 μg mLG1 (0.02 g of sulfonamide dissolved in 20 mL
distilled water).  All  the  plates  were  incubated  at 37°C for
24 h. The assay was conducted at regular intervals of 24 h
until marked decline in the potency of the sulfonamide
solution to inhibit the growth of the test organisms was
noticed. Zones of clearance round each well means inhibition
and the diameter of such zones were measured. The procedure
was repeated for the streptomycin (standard).
Determination of Minimum Inhibitory Concentration
(MIC): Agar well dilution method as described by Russell and
Furr (1977) was used to determine the Minimum Inhibitory
Concentration (MIC) of the sulfonamides and streptomycin
(Russell and Furr, 1977). Different dilutions of the
sulfonamides were prepared first at #100 μg mLG1  to give
final concentrations in the range of 100, 50, 25, 12.5, 6.25 and
3.13 μg mLG1. The different dilutions of sulfonamide
derivatives that could not inhibit the  microbial  growth at
#100 μg mLG1 were later prepared at #1000 μg mLG1 to give
final concentrations  in  the  range  of  1000, 500,  250, 125,
62.5 μg mLG1. Two milliliter of each dilution was mixed with
18 mL of Mueller Hinton agar (MHA, Difco, France) and
poured into petri-dishes and allowed to set. The agar was
streaked with an overnight broth culture of the bacterial strains
and incubated overnight. The plates were then examined for
the presence or absence of growth. The minimum
concentration that completely inhibited macroscopic growth
was regarded as the minimum inhibitory concentration of the
respective sulfonamide. The procedure was repeated for
streptomycin (standard). 
RESULTS AND DISCUSSION
Chemistry: In the continuation of our effort on the exploration
of sulfonamide derivatives as potential antibacterial agent for
future drug discovery (Ajani et al., 2013), we have herein
evaluated the in vitro antibacterial screening using α-toluene
sulfonamide and their N,N-diethyl substituted amido bearing
template. The activity recorded therein was compared with that
of p-toluene in order to establish the relevance of CH2/CH3 in
specific position requested via structure-activity relationship
study. The reaction of p-toluenesulfonyl chloride (p-TsCl) with
a typical amino acid, L-proline resulted in  the  formation  of
p-toluenesulfonamide p-T1a in excellent yield. Molecular
diversity was further expanded by the reaction of the p-TsCl
with ten other amino acids to afford  p-toluene sulfonamides
p-T2b-k. These sulfonamide derivatives were further reacted
with diethylamine under swern oxidation strategy, making use
of oxalyl chloride/DMF, to afford various N,N-diethylamido
bearing p-toluenesulfonamides p-T2a-k (Fig. 1). In a similar
manner, reaction of α-toluenesulfonyl chloride with various
amino acids gave α-toluene sulfonamides α-T1a-k which upon
subsequent amidation gave their  N,N-diethylamido  bearing
α-toluenesulfonamides α-T2a-k (Fig. 2). Comparative study of
the synthesis of p-toluenesulfonamides p-T1a-k with  that  of
α-toluenesulfonamides α-T1a-k was evaluated. From the
reaction optimization study, it was discovered that  when  the
α-toluenesulfonyl chloride (α-TsCl) synthon was replaced with
p-toluenesulfonyl chloride, there was an entirely different
chemical behavioral pattern exhibited due to  high  polarity  of
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Fig. 1: Synthetic conversion of  p-tolylsulfonamide  intermediates  to  N,N-diethylamido-s-sulfonamides,  reaction  condition,
(a)  Na2CO3/H2O,  (b)  0°C  to  rt,  4  h, (c) 20% HCI  to  pH 2.2,  (d) (COCI)2,  DMF,  H2O,  NH(CH2CH3)2,  TEA,  DCM,
-10°C (1 h), 0°C (1 h), rt, (1 h)
Fig. 2: Synthetic  conversion  of  α-tolylsulfonamide  intermediates  to  N,N-diethylamido-s-sulfonamides,  reaction  condition,
(a) Na2CO3/H2O, (b) 0°C to rt,  48  h, (c) 2N HCI  to  pH 2.2,  (d) (COCI)2,  DMF,  H2O,  NH(CH2CH3)2,  Na2CO3,  H2O,
-10°C (1 h), rt, (1 h)
the sulfonamides α-T1a-k obtained from the α-toluenesulfonyl
chloride  as  compared  with  that  of  p-toluenesulfonamides
p-T1a-k obtained from p-toluenesulfonyl chloride. This was
because p-toluenesulfonamides p-T1a-k  easily  crystallized
out  of   water   after  acidification  to  pH  2  whereas,  that of
α-toluenesulfonamides  α-T1a-k  still  remained  in   solution
at   that   same   pH.    In    fact,    all    effort    to   crystallized
α-toluenesulfonamides α-T1a-k from water after acidification
proved abortive, until the solution was lyophilized in the
freeze drier, after which the α-toluenesulfonamides α-T1a-k
were obtained in excellent yields.
Antibacterial activity: The antimicrobial sensitivity testing of
the twenty-two sulfonamide derivatives synthesized were
assayed using agar diffusion technique against the test
organisms. Prior to the assay, the bacterial isolates were tested
for viability by resuscitating the organisms in buffered peptone
broth, after which it was sub-cultured into nutrient agar
medium and incubated at 37°C for 24 h. The  isolates  were
sub-cultured in a nutrient broth at 37°C for 8 h prior to
antibacterial testing. The Mueller Hinton agar was inoculated
with the test organisms and solutions of the different
synthesized compounds dissolved in DMSO were  aseptically
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introduced into the bored holes. Streptomycin was used as
reference clinical standards for the antibacterial activities. In
addition, the choice of S. aureus and E. coli as the targeted
organisms in this study was due to wide range of infectious
diseases and life threatening conditions associated with such
isolates. S. aureus which produces heat stable toxin, is among
the invasive gram positive known as pyogenic cocci implicated
in several diseases of human (Nwinyi et al., 2009). From
literatures, S. aureus had shown to be very resistant to a wide
variety of antibiotics (Nwinyi et al., 2008). Infections caused
by methicillin resistant S. aureus (MRSA) and vancomycin
resistant S. aureus are associated with high morbidity and
mortality, high treatment cost and long stays in hospitals
(Nwinyi et al., 2008). Escherichia coli, a facultative anaerobe
of wide distribution in the environment, has been implicated in
the cause of urinary tract infections, meningitis, sepsis, wound
infections, nosocomial pneumonia and arthritis. A subgroup
enterohemorrhagic E. coli (EHEC) can cause severe
potentially fatal illness known as hemorrhagic colitis with
symptoms of blood diarrhea and severe abdominal pain
(Dolores and Doyle, 2001). The result of the zones of
inhibition of the p-toluenesulfonamides p-T2a-k as compared
with that of α-toluenesulfonamides α-T2a-k was as presented
in Fig. 3. The zones of inhibition of the p-T2a-k on S. aureus
ranged from 10-28 mm while that of α-T2a-k was observed to
range from 6-32  mm.   All   α-toluenesulfonamides   had
larger zones of  inhibition  compared  to   their   corresponding
p-toluenesulfonamide  derivatives  p-T2a-k   against  S. aureus
except in α-T2e and α-T2j. When compared with streptomycin,
four compounds (p-T2j, p-T2k, α-T2a and α-T2j) showed
larger zones of inhibition than streptomycin against S. aureus.
Although,  most  of   the   p-toluenesulfonamide   derivatives
p-T2a-k showed larger zones of inhibition than their α-toluene
sulfonamide counterparts p-T2a-k, yet the largest zone of
inhibition against E. coli still emanated from the α-toluene
sulfonamide motif α-T2j with zones of inhibition of 33 mm
(Fig. 4).
Furthermore, Minimum Inhibitory Concentration (MIC)
test was carried out on the tested organisms using methods of
Russell and Furr (1977). The result is shown in Table 1. The
MIC values of the p-T2a-k ranged from 25-1000 mg mLG1
against S. aureus while that of α-T2a-k against the same
organism varied between 3.2 and 500 mg mLG1. On the other
hand, the MIC values  of  both  p-T2a-k and α-T2a-k  against
E. coli ranged from 12.5 to 500 mg mLG1. From the overview
of the Structure Activity Relationship (SAR) study, it was
discovered that the insertion of CH2 between Ph and SO2
contributed immensely to the increase in antibacterial activity
observed in α-T2a-k as compared with p-T2a-k, where the SO2
is directly linked to the Ph ring. The results showed that this
skeletal framework exhibited marked potency as antibacterial
agents. The most active antibacterial agent against S. aureus
and  E. coli were α-T2a and α-T2j respectively. The significant
antibacterial activity of the synthesized compounds may be
explained by the ability of its sulfonamide binding site to
mimic  p-aminobenzoic  acid  (PABA)  which  is  an   essential
Fig. 3: Comparative study of antibacterial activity of p-T2a-k and α-T2a-k against Staphylococcus aureus
Fig. 4: Comparative study of antibacterial activity of p-T2a-k and α-T2a-k against Escherichia coli
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Table 1: Result of MIC test of p-T2a-k and α-T2a-k on targeted organisms
(mg mLG1)
Comp No. S. aureus E. coli Comp No. S. aureus E. coli
p-T2a 100 50 α-T2a 3.12 50
p-T2b 125 62.5 α-T2b 250 250
p-T2c 250 50 α-T2c 62.5 50
p-T2d 250 25 α-T2d 500 250
p-T2e 250 500 α-T2e 50 62.5
p-T2f 250 250 α-T2f 25 62.5
p-T2g 1000 62.5 α-T2g 500 500
p-T2h 250 125 α-T2h 125 62.5
p-T2i 250 125 α-T2i 125 62.5
p-T2j 25 12.5 α-T2j 25 12.5
p-T2k 125 25 α-T2k 25 25
Str. 125 6.25 Str. 125 6.25
MIC: Minimum inhibitory concentration (mg mLG1),  E. coli  ATCC  25922,
S. aureus ATCC 6538, Str.: Streptomycin clinical reference
growth factor in the targeted organisms as earlier documented
in literatures. The explanation for this encouraging activity of
the synthesized sulfonamides could be traceable to the mode
of action of sulfonamide drugs. This is based on the inhibition
of DNA synthesis (Perez-Trallero and Iglesias, 2003) by
interfering with para-aminobenzoic acid (PABA) in
biosynthesis of folic acid (Levin et al., 2007).
CONCLUSION 
Accordingly, the need to develop new and safer
therapeutic agents has motivated the present design, synthesis
and comparative study of antibacterial activity of two series of
sulfonamides p-T2a-k and α-T2a-k derivatives as potential
antibacterial agent against S. aureus and E. coli infection. The
syntheses were successfully achieved and duly validated with
physico-chemical analysis and spectroscopic means. The
results  herein   suggest   that   these   α-toluenesulfonamides
α-T2a-k may have potential as structural templates in the
subsequent design and development of new antibacterial agent
against the action of S. aureus and E. coli. Hence, compounds
α-T2a and α-T2j are good candidates for further study for
future drug discovery.
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